LETTER
An Axially Chiral Phosphine-Oxazoline Ligand
1187
Table 2 Palladium-Catalyzed Allylic Alkylation of 1,3-Diphenyl-
In conclusion, we have developed a novel chiral phos-
phine-oxazoline ligand 3 with an axis-unfixed biphenyl
backbone existing as a mixture of two diastereomers in
equilibrium in solution. It was found that when this com-
pound coordinated to palladium(II), only one of the two
possible kinds of diastereomer complexes with different
axial chirality was formed. With this compound as a chiral
ligand, up to 90% ee was attained for the palladium-cata-
lyzed asymmetric allylic alkylation.
2-propenyl Acetatea
Ligand
Solvent
Base
Yield (%) ee, %b
(config)c
3a
THF
BSA–KOAc
BSA–KOAc
BSA–KOAc
BSA–KOAc
BSA–KOAc
BSA–KOAc
96
89
97
96
93
91
83 (S)
CH2Cl2
THF
82 (S)
88 (S)
90 (S)
85 (S)
90 (R)
3b
CH2Cl2
THF
Acknowledgment
(aS)-2a4
(aR)-2a4
This work was partly supported by the Excellent Young Teachers
Program of MOE, P. R. C., the National Natural Science Foundati-
on of China (No. 20572070) and STCSM Foundation of Shanghai
(03DZ19205).
THF
a Conducted at r.t. with 1,3-diphenyl-2-propenyl acetate (1 mmol),
dimethylmalonate (3 mmol), BSA (3 mmol), and KOAc (20 mmol) in
3 mL of solvent under argon in the presence of the catalyst which
was prepared from ligand (30 mmol) and [Pd(h3-C3H5)Cl]2 (13 mmol)
in 1 mL solvent for 1 h before use. All of the reactions finished within
1 h.
References and Notes
(1) (a) Bolm, C. Angew. Chem., Int. Ed. Engl. 1991, 30, 542.
(b) Pfaltz, A. Acc. Chem. Res. 1993, 26, 339. (c) Togni, A.;
Venanzi, L. M. Angew. Chem., Int. Ed. Engl. 1994, 33, 497.
(d) Williams, J. M. J. Synlett 1996, 705. (e) Ghosh, A. K.;
Mathivanan, P.; Cappiello, J. Tetrahedron: Asymmetry
1998, 9, 1. (f) Pfaltz, A. Synlett 1999, 835. (g) Rechavi, D.;
Lemaire, M. Chem. Rev. 2002, 102, 3467. (h) Desimoni,
G.; Faita, G.; Quadrelli, P. Chem. Rev. 2003, 103, 3119.
(i) McManus, H. A.; Guiry, P. J. Chem. Rev. 2004, 104,
4151. (j) Meyers, A. I. J. Org. Chem. 2005, 70, 6137.
(2) Selected papers: (a) Uozumi, Y.; Kato, K.; Hayashi, T. J.
Am. Chem. Soc. 1997, 119, 5063. (b) Uozumi, Y.; Kato, K.;
Hayashi, T. J. Org. Chem. 1998, 63, 5071. (c) Ogasawara,
M.; Yoshida, K.; Kamei, H.; Kato, K.; Uozumi, Y.; Hayashi,
T. Tetrahedron: Asymmetry 1998, 9, 1779. (d) Uozumi, Y.;
Kyota, H.; Kato, K.; Ogasawara, M.; Hayashi, T. J. Org.
Chem. 1999, 64, 1620. (e) Imai, Y.; Zhang, W.; Kida, T.;
Nakatsuji, Y.; Ikeda, I. Synlett 1999, 1319. (f) Kodama, H.;
Ito, J.; Hori, K.; Ohta, T.; Furukawa, I. J. Organomet. Chem.
2000, 603, 6. (g) Imai, Y.; Matsuo, S.; Zhang, W.;
Nakatsuji, Y.; Ikeda, I. Synlett 2000, 239. (h) Gladiali, S.;
Loriga, G.; Medici, S.; Taras, R. J. Mol. Catal. A: Chem.
2003, 196, 27.
b Determined by HPLC (Chiralcel OD).
c Determined by comparing the sign of its optical rotation with litera-
ture data.
Finally, the stability and reactivity of reaction intermedi-
ates (S)-9 were examined. For both (S)-9a and (S)-9b, two
diastereomeric intermediates with W- and M-type were
observed in their 1H NMR and 31P NMR spectrum in the
ratio of 54:46 and 58:42, respectively (Scheme 4). The
major was assigned as W-type by NOE observation be-
tween the proton of the substituent on oxazoline and Ha,
and the minor was assigned as M-type by observing no
NOE (Scheme 4). For the asymmetric alkylation, it is
known that, because the trans effect directs nucleophilic
attack to the allylic terminus trans to phosphorus atom,10
the W-type intermediate leads to the product of R con-
figuration, and the M-type one leads to the product of S
configuration.11 In the present case, with both 9a and 9b,
the S-configured product was obtained. This result shows
that the minor M-type diastereomer has much more reac-
tivity than the major W-type one, due to the position trans
to the phosphorus atom becoming more cationic, caused
by the steric repulsion between the substituent on oxazol-
ine ring and phenyl group.
(3) (a) Imai, Y.; Zhang, W.; Kida, T.; Nakatsuji, Y.; Ikeda, I.
Tetrahedron Lett. 1997, 38, 2681. (b) Imai, Y.; Zhang, W.;
Kida, T.; Nakatsuji, Y.; Ikeda, I. J. Org. Chem. 2000, 65,
3326.
(4) Imai, Y.; Zhang, W.; Kida, T.; Nakatsuji, Y.; Ikeda, I.
Tetrahedron Lett. 1998, 39, 4343.
(5) Compound 3a: 1H NMR (400 MHz, CDCl3; major/
minor = 57:43 in CDCl3): d = 7.89 (dd, J = 1.5, 7.7 Hz, 1 H),
7.88 (dd, J = 1.5, 7.7 Hz, 1 H), 7.38–7.07 (m, 32 H), 6.89 (br
d, J = 7.7 Hz, 1 H), 4.09 (dd, J = 8.4, 9.5 Hz, 1 H), 4.01 (dd,
J = 6.6, 8.1 Hz, 1 H), 3.90–3.80 (m, 3 H), 3.69 (t, J = 8.4 Hz,
1 H), 1.71–1.62 (m, 1 H), 1.61–1.52 (m, 1 H), 0.84 (d,
J = 7.0 Hz, 3 H), 0.80 (d, J = 7.0 Hz, 3 H), 0.84 (d, J = 6.9
Hz, 3 H). 31P NMR (CDCl3, PPh3 = –6.0 ppm): d = –14.8
(major), –15.0 (minor). HRMS (EI): m/z calcd for
O
O
N
Ph2P
Ph
Ph2P
Ph
N
Ha
Pd
Pd
R
Ph
R
Ph
Ha
9a,b
a: R = i-Pr; b: R = t-Bu
M-type
minor
W-type
major
C30H28NOP: 449.1910; found: 449.1905. Anal. Calcd for
C31H30NOP: C, 80.16; H, 6.28; N, 3.12. Found: C, 79.78; H,
5.89; N, 3.11. [a]D25 = –54.2 (c 0.48, CHCl3).
9a: 0.4%
9b: 2.8%
no NOE
NOE:
Compound 3b: 1H NMR (400 MHz, CDCl3, major/
minor = 53:47 in CDCl3): d = 7.89 (dd, J = 1.1, 7.7 Hz, 1 H),
7.88 (dd, J = 1.1, 7.7 Hz, 1 H), 7.39–7.07 (m, 32 H), 6.88 (br
d, J = 8.1 Hz, 1 H), 6.83 (br d, J = 8.1 Hz, 1 H), 4.06–3.93
(m, 3 H), 3.89–3.75 (m, 3 H), 0.81 (s, 9 H), 0.73 (s, 9 H).
Scheme 4
Synlett 2006, No. 8, 1185–1188 © Thieme Stuttgart · New York